Home/Recalls/CANADA-50027
Health CanadaGeneral Alert

RITUXAN (rituximab) - Hepatitis B Virus (HBV) Recurrence in Patients: Updates on...

Published: July 29, 2013Recall ID: 50027Category: generalCountry: Canada

Reason for Recall / Hazard

Product safety

Product Description & Identification

RITUXAN (rituximab) - Hepatitis B Virus (HBV) Recurrence in Patients: Updates on Screening and Management - For Health Professionals

Additional Source Details

FieldValue
N I D50027
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/rituxan-rituximab-hepatitis-b-virus-hbv-recurrence-patients-updates-screening-and-0
IssueProduct safety
Title RITUXAN (rituximab) - Hepatitis B Virus (HBV) Recurrence in Patients: Updates on Screening and Management - For Health Professionals
Archived1
CategoryBiologic or vaccine
Last updated2013-07-29
OrganizationMarketed health products

Overview

  • Recalling FirmMarketed health products
Official Agency Alert